CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-17 | Fraser John D Director | Purchase | +16,389 | $0.45 | $7K | 566,393 |
| 2025-09-17 | Fraser John D Director | Purchase · Warrant (Right to Buy) | +12,292 | 981,549 | ||
| 2025-09-02 | Hungerford Brian Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-06-04 | Vos Ellen O'Connor Director | Option exercise | +5,312 | 73,989 | ||
| 2025-06-04 | Vos Ellen O'Connor Director | Option exercise · Restricted Stock Units | −5,312 | 0 | ||
| 2025-06-04 | Ragard John Phillip Director | Option exercise | +4,844 | 134,734 | ||
| 2025-06-04 | Ragard John Phillip Director | Option exercise · Restricted Stock Units | −4,844 | 0 | ||
| 2025-06-04 | Cavanaugh Stefanie L. Director | Option exercise | +5,937 | 78,726 | ||
| 2025-06-04 | Cavanaugh Stefanie L. Director | Option exercise · Restricted Stock Units | −5,937 | 0 | ||
| 2025-06-04 | Herchuk Jannie Prestridge Director | Option exercise | +8,437 | 82,502 | ||
| 2025-06-04 | Herchuk Jannie Prestridge Director | Option exercise · Restricted Stock Units | −8,437 | 0 | ||
| 2025-06-04 | Parnell Winfred Director | Option exercise | +5,156 | 71,209 | ||
| 2025-06-04 | Parnell Winfred Director | Option exercise · Restricted Stock Units | −5,156 | 0 | ||
| 2025-06-04 | Beausang Ellen Director | Option exercise | +4,843 | 6,458 | ||
| 2025-06-04 | Beausang Ellen Director | Option exercise · Restricted Stock Units | −4,843 | 0 | ||
| 2025-05-22 | Buhle Michael William Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 | ||
| 2025-05-13 | cohen Jeffrey k Director | Grant or award | +11,653 | $0.07 | $816 | 60,913 |
| 2025-05-09 | cohen Jeffrey k Director | Grant or award | +44,260 | $0.07 | $3K | 49,260 |
| 2025-03-31 | Vos Ellen O'Connor Director | Option exercise | +5,313 | 68,677 | ||
| 2025-03-31 | Vos Ellen O'Connor Director | Option exercise · Restricted Stock Units | −5,313 | 5,312 |
Page 2 of 15 · 296 trades